KR101469807B1 - Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom - Google Patents

Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom Download PDF

Info

Publication number
KR101469807B1
KR101469807B1 KR1020130013030A KR20130013030A KR101469807B1 KR 101469807 B1 KR101469807 B1 KR 101469807B1 KR 1020130013030 A KR1020130013030 A KR 1020130013030A KR 20130013030 A KR20130013030 A KR 20130013030A KR 101469807 B1 KR101469807 B1 KR 101469807B1
Authority
KR
South Korea
Prior art keywords
mushroom
lactobacillus
fermented
extract
compositions containing
Prior art date
Application number
KR1020130013030A
Other languages
Korean (ko)
Other versions
KR20140100140A (en
Inventor
염교선
이고은
윤태영
김종귀
Original Assignee
주식회사 아이피어리스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아이피어리스 filed Critical 주식회사 아이피어리스
Priority to KR1020130013030A priority Critical patent/KR101469807B1/en
Publication of KR20140100140A publication Critical patent/KR20140100140A/en
Application granted granted Critical
Publication of KR101469807B1 publication Critical patent/KR101469807B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Abstract

본 발명은 락토바실러스(Lactobacillus) 균주를 이용한 운지버섯 발효추출물이 항산화에 도움을 주는 화장품 원료 조성물에 관한 것으로 에탄올 추출물보다 발효 후 활성이 뛰어나다는 것을 확인하였다. 락토바실러스 아시도필루스(Lactobacillus acidophilus)로 발효 추출한 운지버섯은 자유라디칼과 활성산소를 소거하고, 락토바실러스 플란타룸(Lactobacillus plantarum)으로 발효 추출한 운지버섯은 활성산소를 소거함으로써 그 효과를 나타내는 것이다.The present invention relates to a raw material composition for cosmetics which is useful for antioxidation of Fungus mushroom fermentation extract using Lactobacillus strain, and it is confirmed that the extract has better activity after fermentation than ethanol extract. Fungus mushroom fermented with Lactobacillus acidophilus clears free radicals and free radicals, and Fungus mushroom fermented with Lactobacillus plantarum has the effect of eliminating free radicals .

Description

운지버섯 발효추출물을 포함하는 화장료 조성물{COSMETIC COMPOSITIONS CONTAINING FERMENTED EXTRACTS OF CORIOLUS VERSICOLOR MUSHROOM}COSMETIC COMPOSITIONS CONTAINING FERMENTED EXTRACTS OF CORIOLUS VERSICOLOR MUSHROOM [0002]

본 발명은 락토바실러스(Lactobacillus) 균주를 이용한 운지버섯 발효추출물의 항산화 활성에 관한 것이다. 또한, 상기 추출물은 자유라디칼 소거 및 활성산소 소거능이 우수함을 확인하고 이 효능을 가지는 위 추출물의 항산화제로서의 용도에 관한 것이다.
The present invention relates to an antioxidant activity of a fermented mushroom fermentation extract using Lactobacillus strain. In addition, the above extract is excellent in free radical scavenging activity and oxygen scavenging ability, and relates to the use of gastric extract having this effect as an antioxidant.

산소는 호흡을 하는데 필요하지만 노화, 관절염, 암 등 다양한 질병을 일으키는데 직간접적으로 관여하고 있다. 이것은 활성화된 산소종을 말하는데 이것은 자유라디칼로 세포의 면역 반응, 세포 내에서 에너지 생성 반응, 자외선, 스트레스, 세균 등에 의해서 생성된다. 또한 체내에서 생성되면 세포를 파괴하거나 주름 형성, 피부암, 아토피성 피부염, 여드름 등 여러 가지 문제를 일으킨다고 알려져 있다. 항산화 물질은 동, 식물계에 널리 분포되어 있으며 과일, 채소에 많은 페놀성 화합물, 플라보노이드, 토코페롤, 비타민 C 와 같은 물질들이 지질의 산화를 지연시키거나 방지하여 노화를 방지시킨다.
Oxygen is needed to breathe but it is directly or indirectly involved in causing various diseases such as aging, arthritis, and cancer. This refers to activated oxygen species, which are free radicals produced by cellular immune responses, intracellular energy production reactions, ultraviolet light, stress, and bacteria. It is also known that when it is produced in the body, it destroys cells or causes various problems such as wrinkles, skin cancer, atopic dermatitis and acne. Antioxidants are widely distributed in copper and plants. Many phenolic compounds, flavonoids, tocopherols, and vitamin C in fruits and vegetables prevent or retard oxidation of lipids and prevent aging.

한국특허등록 제10-0775133호Korea Patent No. 10-0775133

본 발명의 목적은 운지버섯의 에탄올 추출물보다 항산화 효과가 우수한 운지버섯의 발효추출물을 제공하는 것이다. It is an object of the present invention to provide a fermented extract of chestnut mushroom having an antioxidant effect superior to the ethanol extract of chestnut mushroom.

상기 본 발명의 목적은 운지버섯을 락토바실러스(Lactobacillus) 균주로 발효함으로써 얻을 수 있다. The object of the present invention can be attained by fermenting Mushroom mushroom with Lactobacillus strain.

운지버섯을 물과 에탄올을 혼합용매로 사용하여 상온에서 추출하고 락토바실러스 균주를 적당한 비율로 운지버섯 추출물과 혼합하여 37도에서 배양한다.Fungus mushroom is extracted at room temperature using water and ethanol as a mixed solvent. Lactobacillus strains are mixed at a suitable ratio with the mushroom extract and cultured at 37 ° C.

에탄올 추출물보다 락토바실러스 균주를 가장 좋은 비율로 혼합하였을 때 발효추출물이 항산화 효과가 더 우수하다.
The fermented extract has the better antioxidative effect when the Lactobacillus strain is mixed at the best ratio than the ethanol extract.

도 1은 본 발명의 운지버섯 비발효와 락토바실러스 아시도필루스(Lactobacillus acidophilus) 발효 추출물의 농도에 따른 자유라디칼과 활성산소 소거효과를 나타낸 그림이다.
도 2는 본 발명의 운지버섯 비발효와 락토바실러스 플란타룸(Lactobacillus plantarum) 발효 추출물의 농도에 따른 자유라디칼과 활성산소 소거효과를 나타낸 그림이다.
도 3은 본 발명의 운지버섯 비발효와 락토바실러스 아시도필루스(Lactobacillus acidophilus) 발효 추출물의 농도에 따른 세포독성을 나타낸 그림이다.
도 4는 본 발명의 운지버섯 비발효와 락토바실러스 플란타룸(Lactobacillus plantarum) 발효 추출물의 농도에 따른 세포독성을 나타낸 그림이다.
1 is a loose-fill (Lactobacillus FIG fingering mushroom non fermented with Lactobacillus know of the present invention acidophilus ) fermentation extracts.
FIG. 2 is a graph showing free radical and reactive oxygen scavenging effect according to the concentration of the fermented extract of L. bifuscolius Lactobacillus plantarum according to the present invention.
3 is loose-fill (Lactobacillus FIG fingering mushroom non fermented with Lactobacillus know of the present invention acidophilus ) fermentation extracts.
FIG. 4 is a graph showing the cytotoxicity according to the concentration of the fermented extract of Lactobacillus plantarum and the non-fermented fungus mushroom of the present invention.

본 발명에 사용된 운지버섯은 구멍장이 버섯과의 진균류 구름버섯(Coriolus versicolor (LINNE) FR.)의 균사체이다. 폐의 질환을 치료하는 효력, B형 간염, 지연성 간염, 만성 활동성 간염 및 간암의 예방과 치료에 효력이 있고, 면역증강 효과가 우수하다. 운지버섯의 주요 성분은 다당체로 운지버섯의 세포벽을 구성하는 물질은 글루칸이다. 글루칸은 항종양제의 주성분으로 고가 의약품화 되어있다.
The fingi mushroom used in the present invention is a mycelium of mushroom and mushroom ( Coriolus versicolor (LINNE) FR.). Efficacy in the treatment of lung diseases, hepatitis B, delayed hepatitis, chronic active hepatitis and hepatocarcinoma. The main component of the fungus mushroom is polysaccharide, and the substance that constitutes the cell wall of fungus mushroom is glucan. Glucan is a major component of antitumor drugs and is a high-priced medicine.

이하 본 발명을 실시예와 시험예를 통해 보다 상세하게 설명한다.
Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples.

실시예
Example

실시예1. 70% 에탄올을 이용한 추출법Example 1. Extraction method using 70% ethanol

운지버섯과 70% 에탄올을 1:10 중량비로 혼합하여 상온에서 24시간 진탕 추출하였다.
Fenugami mushroom and 70% ethanol were mixed at a weight ratio of 1:10 and extracted with shaking at room temperature for 24 hours.

실시예2. 락토바실러스 아시도필루스(Lactobacillus acidophilus) 균주를 이용한 발효 추출법Example 2. Lactobacillus < RTI ID = 0.0 > acidophilus )

에탄올 추출물 20%와 락토바실러스 아시도필루스(OD600=0.4) 20%를 혼합하여 37도에서 19시간 진탕 추출하였다.
20% ethanol extract and 20% Lactobacillus acidophilus (OD 600 = 0.4) were mixed and extracted with shaking at 37 ° C for 19 hours.

실시예3. 락토바실러스 플란타룸(Lactobacillus plantarum) 균주를 이용한 발효 추출법 (1)Example 3. Lactobacillus ( Lactobacillus) Fermentation Extraction Method Using Plantarum Strains (1)

에탄올 추출물 20%와 락토바실러스 플란타룸 (OD600=0.1) 0.6%를 혼합하여 37도에서 24시간 진탕 추출하였다.
20% ethanol extract and 0.6% Lactobacillus plantarum (OD 600 = 0.1) were mixed and shaken at 37 ° C for 24 hours.

실시예4. 락토바실러스 플란타룸(Lactobacillus plantarum) 균주를 이용한 발효 추출법 (2)Example 4. Lactobacillus ( Lactobacillus) fermentation extraction method (2) using a plantarum) strains

에탄올 추출물 10%와 락토바실러스 플란타룸 (OD600=0.4) 20%를 혼합하여 37도에서 24시간 진탕 추출하였다.
10% ethanol extract and 20% Lactobacillus plantarum (OD 600 = 0.4) were mixed and shaken at 37 ° C for 24 hours.

시험예 Test Example

시험예1. DPPH에 의한 자유라디칼 소거법에 따른 환원 활성Test Example 1 Reduction activity by free radical scavenging method by DPPH

1,1-디페닐-2-피크릴-히드라진 (DPPH, 1,1-diphenyl-2-picryl hydrazyl, Sigma, USA)은 화학적으로 안정화된 자유라디칼을 가지고 있는 수용성 물질로 520nm 부근에서 최대 흡광도를 가지며, 항산화 활성이 있는 물질과 만나면 전자를 내어주면서 라디칼 (DPPH)이 소멸되고 색깔이 변한다. 화학적으로 안정성 있는 DPPH은 여러 종의 항산화 성분이 내재된 추출물, 음료와 오일, 순수 페놀화합물 등의 항산화 효과를 분석 할 수 있다. 이 실험은 DPPH로 먼저 산화를 개시한 후 시료에 의해서 라디칼에 대한 소거되는 활성을 알아보기 위한 실험이다. DPPH를 메탄올에 용해시킨 0.2mM의 DPPH 용액 1mL에 각 농도의 실시예 1의 에탄올 추출물과 실시예 2,3,4의 발효추출물을 첨가하였다. 실온에서 10분간 반응시킨 후 ELISA reader (Plus384, Molecular Device, USA)로 525nm에서 흡광도를 측정하였다. 대조군은 시료 액과 DPPH용액 대신 메탄올을 넣어 보정 값을 얻는다. 자유라디칼 소거율은 아래의 식에 따라 계산하였다.(DPPH, 1,1-diphenyl-2-picryl hydrazyl, Sigma, USA) is a chemically stabilized water-soluble material with a free radical and has a maximum absorbance at around 520 nm And if it meets a substance with antioxidant activity, the radical (DPPH) disappears and the color changes while giving electrons. Chemically stable DPPH can be used to analyze the antioxidative effects of various types of antioxidant extracts, beverages, oils, and pure phenolic compounds. This experiment is an experiment to examine the activity of scavenging by radicals after initiating oxidation first with DPPH. The ethanol extract of Example 1 and the fermented extracts of Examples 2, 3 and 4 were added to 1 mL of 0.2 mM DPPH solution in which DPPH was dissolved in methanol. After incubation at room temperature for 10 minutes, the absorbance was measured at 525 nm using an ELISA reader (Plus384, Molecular Device, USA). In the control group, methanol is added instead of the sample solution and the DPPH solution to obtain a correction value. The free radical scavenging rate was calculated according to the following equation.

소거율 (%) = (대조군의 흡광도-시험군의 흡광도) / 대조군의 흡광도 × 100(%) = (Absorbance of control group - absorbance of test group) / absorbance of control group x 100

대조군은 6-히드록시-2,5,6,8-테트라메틸크로만-2-카르복실산 (Trolox, Sigma, USA)를 사용하였다. Trolox는 비타민 E 유사체로 항산화 효능이 뛰어난 물질이다. 활성은 50%를 기준으로 하여 trolox와 비슷하거나 높은 값을 가지는 시료가 활성이 좋은 것으로 간주했다The control group was 6-hydroxy-2,5,6,8-tetramethylchroman-2-carboxylic acid (Trolox, Sigma, USA). Trolox is a vitamin E analogue with excellent antioxidant activity. Samples with similar or higher values to trolox were considered active at 50% activity

락토바실러스 아시도필루스로 발효 추출한 운지버섯은 에탄올 추출보다 약 40% 활성이 더 좋았고 그 결과는 도 1에 기재하였다. 실시예3 조건으로 발효 추출한 운지버섯은 에탄올 추출과 활성이 비슷했고, 실시예4 조건으로 발효 추출한 운지버섯은 에탄올 추출보다 약 10% 활성이 더 좋았다. 그 결과를 도 2에 기재하였다.
Fungus mushroom fermented with Lactobacillus acidophilus was about 40% more active than ethanol extract, and the results are shown in Fig. The extracts of the fungus mushroom fermented under the conditions of Example 3 were similar to those of the ethanol extract, and the fungus mushroom fermented under the condition of Example 4 was about 10% more active than the ethanol extract. The results are shown in Fig.

시험예2. SOD 유사활성 측정Test Example 2 SOD-like activity measurement

활성산소 (Reactive Oxygen Species) 소거활성 (SOD activity)은 크산틴 옥시다아제(Xanthine oxidase) 효소반응에 의한 활성 산소발생계를 이용하여 활성 산소에 의한 NBT (Nitrobluetetrazolium)의 산화에 의한 흡광도 변화를 측정하여 평가한다. 0.05mM Na2CO3 (Yakuri Pure Chemicals Co., Ltd, Japan) 1.2mL, 3mM xanthine (Sigma, USA) 0.05mL, 3mM EDTA (Sigma, USA) 0.05mL, BSA (Sigma, USA) 0.05mL, 0.75mM NBT (Sigma, USA) 0.05mL, 각 시료 (시험예 1과 동일) 0.05mL를 넣고 잘 혼합한 후 25℃에서 10분간 정치시켰다. 크산틴 옥시다아제(Sigma, USA) 0.05mL를 넣고 25℃에서 20분간 반응시킨 후에 6mM CuCl2 (Daejung Chemicals & Metals Co., LTD, Korea) 0.05mL를 넣어 반응을 정지시키고 ELISA reader (Plus 384, Molecular Device, USA)로 560nm에서 흡광도를 측정하였다. 대조군은 시료 대신 정제수를 넣으며, 크산틴 옥시다아제 대신에 정제수를 넣어 색 보정 값을 얻는다. 소거율은 DPPH 자유라디칼 소거율에 사용된 식과 동일하게 계산하였다. 대조군은 비타민C (L-ascorbic acid, Sigma, USA)를 사용하였다. 활성은 50%로 기준하였으며 이와 비슷하거나 높은 값을 가지는 경우 활성이 높은 것으로 간주했다. Reactive Oxygen Species The SOD activity was measured by measuring the absorbance change of NBT (Nitrobluetetrazolium) by reactive oxygen species using the active oxygen generating system by xanthine oxidase enzyme reaction do. 0.05mM Na 2 CO 3 (Yakuri Pure Chemicals Co., Ltd, Japan) 1.2mL, 3mM xanthine (Sigma, USA) 0.05mL, 3mM EDTA (Sigma, USA) 0.05mL, BSA (Sigma, USA) 0.05mL, 0.75 0.05 mL of mM NBT (Sigma, USA) and 0.05 mL of each sample (the same as in Test Example 1) were added, mixed well and allowed to stand at 25 DEG C for 10 minutes. The reaction was stopped by the addition of 0.05 mL of 6 mM CuCl 2 (Daejung Chemicals & Metals Co., LTD, Korea) in 0.05 mL of xanthine oxidase (Sigma, USA) Device, USA) at 560 nm. In the control group, purified water is added instead of the sample, and purified water is added instead of xanthine oxidase to obtain a color correction value. The erasure rate was calculated in the same manner as the equation used for the DPPH free radical scavenging rate. The control group was vitamin C (L-ascorbic acid, Sigma, USA). The activity was rated at 50%, and if similar or higher values were considered, the activity was considered high.

실시예2 조건으로 발효 추출한 운지버섯은 에탄올 추출보다 약 17% 활성이 좋았고 그 결과는 도 1에 기재하였다. 실시예3 조건으로 발효 추출한 운지버섯은 에탄올 추출보다 약 27% 활성이 더 좋았으나 실시예4 조건으로 발효 추출한 운지버섯은 에탄올 추출보다 활성이 적었다. 그 결과는 도 2에 기재하였다.
The fungus extract fermented under the conditions of Example 2 was about 17% more active than the ethanol extract, and the results are shown in FIG. Uncooked mushroom fermented under the condition of Example 3 was about 27% more active than ethanol extract, but the fermented mushroom fermented in Example 4 was less active than ethanol extract. The results are shown in Fig.

시험예3. 세포독성 측정Test Example 3. Cytotoxicity measurement

세포를 3-[4,5-dimethyltjiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT, Amresco)으로 염색시켜 세포의 생존율을 측정한다. 96well plate에 HaCaT 세포를 6×103 cells/well로 분주하고 24시간 배양한다. 시료를 0.1, 0.5, 1, 2%로 처리하고 72시간 배양한다. MTT(5mg/mL)를 4시간 동안 처리 한 후 ELISA reader (Plus 384, Molecular Device, USA)로 570nm에서 흡광도를 측정하였다. 세포 생존율은 80% 이상이면 독성이 없고 80% 이하이면 독성이 있다고 간주했다.Cells are stained with 3- [4,5-dimethyltjiazol-2-yl] -2,5-diphenyl tetrazolium bromide (MTT, Amresco) HaCaT cells are seeded at 6 × 10 3 cells / well on a 96-well plate and cultured for 24 hours. Samples are treated at 0.1, 0.5, 1, 2% and cultured for 72 hours. MTT (5 mg / mL) was treated for 4 hours and absorbance was measured at 570 nm with an ELISA reader (Plus 384, Molecular Device, USA). The cell survival rate was considered to be toxic if 80% or more and less than 80%.

에탄올추출물과 실시예2 조건으로 발효 추출한 운지버섯, 실시예3 조건으로 발효 추출한 운지버섯은 1%까지 독성이 없으나 실시예4 조건으로 발효 추출한 운지버섯은 모든 농도에서 독성이 있었다. 그 결과는 도 3, 도 4에 기재하였다.
The ethanol extracts and the unmixed mushrooms fermented under the conditions of Example 2 and 3 were not toxic up to 1%, but the mushrooms extracted from the fermented mushrooms under the conditions of Example 4 were toxic at all concentrations. The results are shown in Fig. 3 and Fig.

운지버섯을 락토바실러스 균주로 발효함으로써 항산화 효과가 더 우수하고 화장품 원료에 적용할 수 있다. 운지버섯 발효추출물은 자유라디칼 소거효과 및 활성산소 소거효과를 가져 항노화, 항산화 효과를 나타낼 수 있으며 이 기능을 나타내는 제품에 적용할 수 있다.
Fungus mushroom is fermented as Lactobacillus strain, and it has better antioxidative effect and can be applied to cosmetic raw materials. The extract of Fungus mushroom has free radical scavenging effect and active oxygen scavenging effect and can exhibit anti-aging and antioxidant effect and can be applied to products showing this function.

Claims (4)

운지버섯의 락토바실러스 균주에 의한 발효 추출물을 함유하는 화장료 조성물.
A cosmetic composition comprising a fermented extract by Lactobacillus strain of Mushroom mushroom.
삭제delete 제 1 항에 있어서, 상기 락토바실러스 균주는 락토바실러스 아시도필루스(Lactobacillus acidophilus) 및 락토바실러스 플란타룸(Lactobacillus plantarum)으로부터 선택되는 1종 이상인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the Lactobacillus strain is at least one selected from Lactobacillus acidophilus and Lactobacillus plantarum . 제 3 항에 있어서, 상기 발효 추출물은 운지버섯과 Lactobacillus acidophilus(OD600=0.4)를 각 20% 실험 비율로 발효 추출한 것임을 특징으로 하는 화장료 조성물.


[Claim 4] The cosmetic composition according to claim 3, wherein the fermented extract is fermented and extracted with fungus mushroom and Lactobacillus acidophilus (OD 600 = 0.4) at an experimental ratio of 20%.


KR1020130013030A 2013-02-05 2013-02-05 Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom KR101469807B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130013030A KR101469807B1 (en) 2013-02-05 2013-02-05 Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130013030A KR101469807B1 (en) 2013-02-05 2013-02-05 Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom

Publications (2)

Publication Number Publication Date
KR20140100140A KR20140100140A (en) 2014-08-14
KR101469807B1 true KR101469807B1 (en) 2014-12-05

Family

ID=51746116

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130013030A KR101469807B1 (en) 2013-02-05 2013-02-05 Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom

Country Status (1)

Country Link
KR (1) KR101469807B1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101865688B1 (en) * 2017-02-24 2018-06-11 주식회사 코리아나화장품 Cosmetic composition comprising extracts of Trachelospermum jasminoides, Coptis chinensis and Sophora Japonica as active ingredient
KR101950384B1 (en) * 2017-07-20 2019-02-20 주식회사 코리아나화장품 Cosmetic composition comprising extracts of Trachelospermum jasminoides, Coptis chinensis and Sophora Japonica as active ingredient
KR101998684B1 (en) * 2017-09-06 2019-07-11 주식회사 아미코스메틱 A cosmetic composition comprising juniperus chinensis var. sargentii extract
KR102004366B1 (en) * 2017-09-06 2019-07-29 주식회사 아미코스메틱 A cosmetic composition comprising centipeda minima extract
KR101998685B1 (en) * 2017-09-06 2019-07-11 주식회사 아미코스메틱 A cosmetic composition comprising arenaria serpyllifolia extract
KR102131774B1 (en) * 2018-12-14 2020-07-09 주식회사 코리아나화장품 Cosmetic Composition Containing Extract of Trichaptum Abietinum for Improving Skin Wrinkle

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060106073A (en) * 2005-04-06 2006-10-12 네오바이오다임 주식회사 A MANUFACTURING METHOD OF beta;-GLUCAN HAVING ANTIBACTERIAL OR ANTIVIRAL ACTIVITY AND COSMETIC COMPOSITION COMPRISING beta;-GLUCAN THEREOF
KR101028073B1 (en) * 2010-11-29 2011-04-08 이경란 Natural herb medicine composition improving blood circulation and immune activity of human body and its process of production

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060106073A (en) * 2005-04-06 2006-10-12 네오바이오다임 주식회사 A MANUFACTURING METHOD OF beta;-GLUCAN HAVING ANTIBACTERIAL OR ANTIVIRAL ACTIVITY AND COSMETIC COMPOSITION COMPRISING beta;-GLUCAN THEREOF
KR101028073B1 (en) * 2010-11-29 2011-04-08 이경란 Natural herb medicine composition improving blood circulation and immune activity of human body and its process of production

Also Published As

Publication number Publication date
KR20140100140A (en) 2014-08-14

Similar Documents

Publication Publication Date Title
KR101469807B1 (en) Cosmetic compositions containing fermented extracts of coriolus versicolor mushroom
Zhang et al. Production of powerful antioxidant supplements via solid-state fermentation of wheat (Triticum aestivum Linn.) by Cordyceps militaris
Ma et al. Antioxidant and antibacterial evaluation of polysaccharides sequentially extracted from onion (Allium cepa L.)
Curiel et al. Lactic acid fermentation as a tool to enhance the antioxidant properties of Myrtus communis berries
Xiao et al. Enhancement of the antioxidant capacity of soy whey by fermentation with Lactobacillus plantarum B1–6
Shibata et al. Antioxidant activities of phlorotannins isolated from Japanese Laminariaceae
Huang et al. Vitamin D2 content and antioxidant properties of fruit body and mycelia of edible mushrooms by UV-B irradiation
Di Cagno et al. Bioprocessing technology to exploit organic palm date (Phoenix dactylifera L. cultivar Siwi) fruit as a functional dietary supplement
Gao et al. Antioxidant properties, superoxide dismutase and glutathione reductase activities in HepG2 cells with a fungal endophyte producing apigenin from pigeon pea [Cajanus cajan (L.) Millsp.]
Ahmed et al. Biological capacity and chemical composition of secondary metabolites from representatives Japanese lichens
Park et al. Evaluation of the antioxidant activities and tyrosinase inhibitory property from mycelium culture extracts
Ahmad et al. Antioxidant Properties And Glucan Compositionof Various Crude Extract From Lentinus Squarrosulus Mycelial Culture
Postemsky et al. Enhancement of wheat grain antioxidant activity by solid state fermentation with Grifola spp.
EP2875822B1 (en) Polyphenol extract from white-grape residue
Meechai et al. Antioxidant Properties and Phytochemical Contents of Garcinia schomburgkiana Pierre.
Ko et al. Antioxidant and antiradical activities of Wu Ling Shen in a cell free system
Chang et al. Fractionation, characterization and antioxidant activity of exopolysaccharide from fermentation broth of a Xylaria nigripes
Subramaniam et al. Solid-substrate fermentation of wheat grains by mycelia of indigenous species of the genus Ganoderma (higher Basidiomycetes) to enhance the antioxidant activities
Liu et al. Antioxidant activities of selected medicinal mushroom submerged cultivated mycelia
Milovanović et al. Effect of selenium enrichment of Lenzites betulinus and Trametes hirsuta mycelia on antioxidant, antifungal and cytostatic potential
Xu et al. Antioxidant activity of liquid cultured Inonotus obliquus polyphenols using tween-20 as a stimulatory agent: Correlation of the activity and the phenolic profiles
Jaszek et al. Stimulation of the antioxidative and antimicrobial potential of the blood red bracket mushroom Pycnoporus sanguineus (higher Basidiomycetes)
Elayarani et al. In vitro anti-oxidant activity of the various extracts of Cassia auriculata L. flower by UV spectrophotometer
Nahas et al. Myco-antioxidants: insights into the natural metabolic treasure and their biological effects
Bai et al. Black sesame pigment extract from sesame dregs by subcritical CO2: Extraction optimization, composition analysis, binding copper and antioxidant protection

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant